Patient's Query
Hello doctor,
My 25-year-old nephew has been battling acute lymphoblastic leukemia (ALL) for the past eight months. Unfortunately, conventional chemotherapy has not been very effective, and his oncologist has mentioned that stem-cell therapy might be our only remaining option. However, we are unsure about the risks involved in this therapy.
His white blood cell count is still extremely high (32,000) despite undergoing three rounds of chemotherapy, and he is becoming progressively weaker, having lost 31 pounds. The most recent bone marrow biopsy revealed 68 percent blast cells, and he has had a fever above 101 Degrees Fahrenheit for over a week.
None of our family members are suitable donors, and we have been informed that waiting for an unrelated donor could take months. We are concerned about his chances of success with stem-cell therapy at this point. Are there any clinical trials that might be suitable for him? His oncologist mentioned potential long-term complications, but we were too overwhelmed to fully process all of the information. Could you provide further insights into his situation and the options available?
Please help.
Thank you.
Hi,
Welcome to icliniq.com.
I read your query and can understand your concern.
Acute lymphoblastic leukemia (ALL) is an aggressive form of cancer. Unfortunately, chemotherapy (a treatment that uses powerful drugs to kill or stop the growth of cancer cells or other abnormal cells) is not working, as his white blood cell count remains high and the bone marrow biopsy shows 68 % blast cells, indicating a very high leukemia (a type of blood cancer that develops in the bone marrow, leading to an abnormal production of white blood cells) load. He is also becoming progressively weaker, losing weight, and experiencing a persistent fever. This situation is serious and requires urgent action.
Stem cell therapy, also known as a bone marrow transplant, involves replacing his damaged bone marrow with healthy stem cells. This is often the last chance for a cure when chemotherapy fails.
Main risks:
Infections: His immune system will be significantly weakened after the transplant.
Graft versus. host disease (GVHD): This occurs when the donor's cells attack the recipient's body.
Organ damage, infertility, and long-term immune complications.
However, success remains possible, particularly if the transplant is performed soon and is carefully managed by an experienced transplant team.
No family donor – What is next?
He may be a candidate for one of the following options:
Unrelated matched donor from a registry (though this takes time).
Haploidentical transplant (using a half-match, often from a parent or sibling).
Cord blood transplant: Faster process but with a slower recovery period.
Clinical trials that offer new transplant methods or targeted therapies.
I hope this helps.
Kindly revert so I can assist you further.
Thank you.
Was this conversation helpful?
Answered byDr. Akanksha Agarwal
Medically reviewed byiCliniq medical review team
Same symptoms don't mean you have the same problem. Consult a doctor now!
Related Questions
Multiple Myeloma Diagnosis
Chemotherapy and Blood Cancer
What are the chances of progression of CML with a seven percent blast percentage as per bone marrow biopsy?
Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies
Chemotherapy for Testicular Cancer - An Overview
Childhood Blood Cancer and Its Types
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.
This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy